Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
37,115
Sort by:
2017 Australia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Austria Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Belgium Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Bulgaria Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Cyprus Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Czech Republic Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
March 2017
1120 pages
2017 Denmark Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Estonia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Finland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Greece Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Hungary Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Iceland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Latvia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Lithuania Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Malta Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Netherlands Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Norway Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Poland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Portugal Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Romania Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Slovakia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Slovenia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Sweden Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages